#BioManuDACH2026 | Tech/ Service/ Solution Provider

With the global biologics market expected to surpass $600 billion by 2030, driven by the rise of next-generation modalities and rapid advances in manufacturing technologies, Biologics Manufacturing DACH 2026 offers a premier platform for industry leaders to explore innovation, share expertise, and build strategic partnerships.

As the DACH region strengthens its role as a hub for cutting-edge biologics production, this conference brings together manufacturers, technology providers, and developers to tackle the industry’s most pressing challenges in a focused, highly networked setting.